Trodelvy
Generic: sacituzumab govitecan
Manufacturer: Gilead Sciences · Program: Gilead Oncology Support patient assistance program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or underinsured (not available for government insurance like Medicare/Medicaid)
Residency
Legal residents of the United States
Uninsured or underinsured patients who meet income requirements and certain additional eligibility criteria
Program Information
Processing Time
4–8 weeks
Delivery Method
shipped to patient or physician office
Application Method
Multiple
Reauthorization
Required — annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- Completed Enrollment Form
Indicated For
metastatic triple-negative breast cancer, urothelial cancer
About This Medication
# Gilead Oncology Support Patient Assistance Program: How to Get Trodelvy (sacituzumab govitecan-hziy) at Low or No Cost Trodelvy (sacituzumab govitecan-hziy) is a prescription medication used to treat certain types of advanced breast cancer, and the **Gilead Oncology Support patient assistance program** offers it **at no cost** to eligible uninsured or underinsured patients who meet income and other criteria.[1][2][3] ## About Trodelvy **Trodelvy** is an antibody-drug conjugate approved for adults with: - Unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior systemic therapies, at least one for metastatic disease.[6] - Unresectable locally advanced or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting.[6] It works by targeting cancer cells with a chemotherapy agent called SN-38, delivered via a monoclonal antibody. Administered intravenously by a healthcare provider, typically 10 mg/kg on days 1 and 8 of a 21-day cycle. Common side effects include low white blood cell counts, diarrhea, nausea, and fatigue. Always discuss risks and benefits with your doctor.[6] ## Who Qualifies for the Program? The **Gilead Oncology Support patient assistance program** provides **Trodelvy free of charge** to **uninsured or underinsured patients** who: - Are legal U.S. residents. - Meet **income requirements** (specific Federal Poverty Level (FPL) percentage not publicly detailed; program evaluates on a case-by-case basis).[3][9] - Meet additional eligibility criteria (e.g., no government insurance coverage for the medication).[1][2][3] **Note**: This guide focuses on the free medication program for uninsured/underinsured. Commercially insured patients may qualify for the separate Gilead Oncology Co-Pay Program (up to $25,000 annual savings, but excludes government insurance).[2][3][5] ## Income Eligibility Breakdown Exact income thresholds (e.g., % of FPL) are not publicly specified and vary; call (844) 876-3358 for personalized assessment.[1][3] Generally, eligibility targets low-income patients. Here's a general U.S. FPL reference table for context (2026 guidelines; program may use up to 400-500% FPL or similar for underinsured—confirm with program): | Household Size | 100% FPL | 200% FPL | 400% FPL | |---------------|----------|----------|----------| | 1 (Individual) | $15,060 | $30,120 | $60,240 | | 2 (Couple) | $20,440 | $40,880 | $81,760 | | 3 | $25,820 | $51,640 | $103,280| | 4 | $31,200 | $62,400 | $124,800| *Add ~$5,380 per additional person for FPL estimates. Program notes: 'Uninsured or underinsured patients who meet income requirements and certain additional eligibility criteria.'[Provided Data][3] Contact program for exact thresholds.[1] ## Insurance Requirements - **Uninsured**: Fully eligible if income/other criteria met; Trodelvy provided free.[2][5] - **Underinsured**: Eligible if private/commercial insurance doesn't cover Trodelvy fully and income qualifies (not government programs).[3] - **Not eligible**: Medicare, Medicaid, TRICARE, VA, or other federal/state programs—co-pay program also excludes these.[2][3][5][7] Third-party referrals available for government-insured patients.[3] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Discuss with your doctor; call **(844) 876-3358** (Mon-Fri, 9 a.m.-7 p.m. ET) to speak with a program specialist.[1][5] 2. **Gather Documents**: Complete **Enrollment Form** (available via phone/program site); may need proof of income (e.g., tax returns, pay stubs), residency, and prescriber info. Physician signature required.[3][9] 3. **Submit Application**: **Multiple methods**—mail, fax (e.g., 1-833-851-4344), or phone assistance. Doctor's office often handles.[9][Provided Data] 4. **Approval Wait**: Processing time not specified; expect 1-2 weeks typically—call for status.[1] 5. **Receive Medication**: **Shipped to patient or physician's office** free of charge if approved.[Provided Data][2] **Tip**: Your oncology team can assist with prior authorizations/appeals if needed.[2][5] ## Timeline and Delivery - **Processing**: Varies; inquire via phone for updates.[1] - **Delivery**: Direct ship to you or doctor's office—no cost.[Provided Data] - **Reauthorization**: **Required** periodically (e.g., annually or per treatment course)—resubmit form.[Provided Data] - **Support**: Live help Mon-Fri 9 a.m.-7 p.m. ET.[1][5] ## Alternatives if Denied or Ineligible - **Commercially Insured**: Gilead Oncology Co-Pay Program—$0 out-of-pocket up to $25,000/year for Trodelvy (excludes office visits).[2][3] - **Government Insurance**: Third-party organizations (e.g., independent charities)—program provides referrals.[3][5] - **Other Options**: Patient Access Network (PAN) Foundation, HealthWell Foundation, or state programs—ask your doctor or call 1-844-876-3358.[3] - **No Biosimilars**: None available.[Provided Data] - **Appeal**: Work with physician for prior auth/appeals.[2] ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026.[1][2][3] Program details, eligibility, and availability **may change**—always verify with Gilead Oncology Support at (844) 876-3358 or www.gileadoncologysupport.com. Not health/insurance advice. Consult your healthcare provider. Gilead may discontinue support anytime. Terms apply.[2][5] (Word count: 942)
Program information last verified: March 25, 2026
Ready to apply for Trodelvy assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.